Navigation Links
AMDL Announces Teleconference to Discuss Its Second Quarter 2008 Financial Results
Date:8/15/2008

TUSTIN, Calif., Aug. 15 /PRNewswire-FirstCall/ -- (http://www.amdl.com) AMDL Inc. (Amex: ADL), a world leader in specialty pharmaceuticals with operations in Shenzhen, Jiangxi and Jilin China, announced today its chief executive officer Gary Dreher and chief financial officer Akio Ariura will host a teleconference to discuss the Company's second quarter 2008 financial results. The call is scheduled for Tuesday, August 19, 2008 at 1:45 p.m. Pacific Standard Time (4:45 p.m. Eastern Time).

Existing or potential investors who would like to submit questions prior to the call can do so by emailing Kristine Szarkowitz at kszarkowitz@amdl.com.

To access the live call, please dial (877) 360-1705 in the U.S. or (706) 902-3245 outside the U.S. and reference Conference ID# 60855707 five minutes before the call begins. The conference call script will also be available on the Investor section of the AMDL web site located at http://www.amdl.com. Click on "Investor Relations" then "Recent News" to access the Company's earnings release which was issued today, August 15, 2008, and all other accompanying financial and operating information.

About AMDL:

AMDL Inc. is a global specialty pharmaceutical company. The company is headquartered in Tustin, California with operations in Shenzhen, Jiangxi, and Jilin, China. Along with its subsidiary Jade Pharmaceutical Inc. (JPI), AMDL is devoted to the research, development, manufacture, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products currently in China. The company employs approximately 320 people in the U.S. and China. More information about AMDL and its products can be obtained at http://www.amdl.com.

About Jade Pharmaceutical:

JPI has access to the fastest growing pharmaceutical and consumer market in the world -- China. AMDL, through its Jade subsidiaries, currently holds licenses for 133 products that are manufactured as large volume injection fluids, tablets and other related products. It currently manufactures over 20 key generic, over-the-counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice (CGMP) standards.

AMDL Contact:

Kristine Szarkowitz

Director-Investor Relations

kszarkowitz@amdl.com

(M) (206) 310-5323


'/>"/>
SOURCE AMDL
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Watson Announces District Court Ruling in Naproxen Sodium Patent Suit
2. Sun Pharma Announces U.S. FTC Clearance for Taro Tender Offer
3. Pregis Announces Second Quarter 2008 Financial Results
4. WuXi PharmaTech Announces Second Quarter 2008 Results
5. Assurant Announces Two Executive Appointments
6. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
7. Wound Management Technologies, Inc. Announces Clarification of Eprint Viewing of Case Report in Advances in Skin and Wound Journal
8. Westaim announces 2008 second quarter results
9. Care Investment Trust Inc. Announces an Agreement in Principle for CIT Healthcare to Purchase Mortgage Assets and Reduce Management Fee
10. Barr Announces Agreements to Settle Mirapex(R) and Aggrenox(R) Patent Challenges
11. American HealthChoice Announces Launch of OmniBody Scan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
(Date:9/19/2017)... LOUISVILLE, Ky. , Sept. 19, 2017   ZirMed ... and predictive analytics, today announced that it has been ranked ... the Black Book™ Rankings 2017 User Survey. ZirMed ... software solution for large hospitals and medical centers over 200 ... in Black Book,s healthcare technology user survey history. ...
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
Breaking Medicine Technology: